• Radiation Therapy
      • Treatment Delivery
        • Elekta Unity Elekta Unity
        • Versa HD Versa HD
        • Elekta Harmony Elekta Harmony
        • Elekta Infinity Elekta Infinity
        • Elekta Synergy Elekta Synergy
      • Quality Assurance
        • Machine QA
        • Patient QA
    • Stereotactic Radiosurgery
      • Delivery
        • Elekta Esprit Elekta Esprit
        • Leksell Gamma Knife Icon Leksell Gamma Knife Icon
        • Leksell Gamma Knife Perfexion Leksell Gamma Knife Perfexion
        • Versa HD Versa HD
      • Treatment Planning
        • Leksell Gamma Knife Lightning
        • Leksell GammaPlan
    • Oncology Software
      • Elekta ONE
        • Oncology care
        • Workflow management
        • Treatment applications
        • Real-world outcomes
        • Subscribe to Better
        • Elekta Axis Cloud
        • Interoperability
        • Professional Services
    • Brachytherapy
      • Delivery
        • Elekta Studio Elekta Studio
        • ImagingRing ImagingRing
        • Oncentra Brachy Oncentra Brachy
        • Venezia Venezia
        • Flexitron Flexitron
        • Geneva Geneva
      • Body Sites
        • Head and Neck
        • Bronchus and Oesophagus
        • Breast
        • Skin
        • Prostate
        • Rectum
        • Bladder
        • Gynecology
    • Neurosurgery
      • Delivery
        • Leksell Vantage Stereotactic System Leksell Vantage Stereotactic System
        • Leksell Stereotactic System Leksell Stereotactic System
    • Veterinary Radiation Therapy
    • Life Sciences
      • Elekta Kaiku
    • Elekta Care
    • Elekta Care Support Services
    • Elekta Care 360
    • Elekta Care Learning
    • Elekta Care Community
    • Elekta Partner Community
    • MR-Linac Treatment
    • Brachytherapy Treatment
    • Gamma Knife Treatment
    • Radiation Therapy Treatment
    • Treatment Centers
    • Company
    • Partnering with Elekta
    • About us
      • About us
        • Board of Directors
        • Code of Conduct
        • Corporate Citizenship
        • Executive Committee
        • Integrity Line
        • Programs
        • Risk management
        • Sponsorship and Donation
        • Story
    • Sustainability
    • Corporate Governance
      • Corporate Governance
        • Shareholders’ meetings
          • Board of Directors
            • Executive Committee
              • Auditors
              • Reports
          • Investors
            • Investors
              • Investment case
                • Outlook
                • Market and Trends
                  • The share
                    • Financials
                      • Funding
                        • Reports & presentations
                        • Press releases
                        • IR calendar
                        • IR contacts
                    • Newsroom
                      • Newsroom
                        • Press Releases
                        • FOCUS Magazine
                        • Events
                        • Image bank
                    • Careers at Elekta
                      • Jobs
                    • Reimbursement Support & Policy
                  ENSV
                  Login
                  • Products
                    • Radiation Therapy
                      • Treatment Delivery
                        • Elekta Unity
                        • Versa HD
                        • Elekta Harmony
                        • Elekta Infinity
                        • Elekta Synergy
                      • Quality Assurance
                        • Machine QA
                        • Patient QA
                    • Stereotactic Radiosurgery
                      • Delivery
                        • Elekta Esprit
                        • Leksell Gamma Knife Icon
                        • Leksell Gamma Knife Perfexion
                      • Treatment Planning
                        • Leksell Gamma Knife Lightning
                        • Leksell GammaPlan
                      • Versa HD
                    • Oncology Software
                      • Elekta ONE
                        • Oncology care
                        • Workflow management
                        • Treatment applications
                        • Real-world outcomes
                        • Subscribe to Better
                        • Elekta Axis Cloud
                        • Interoperability
                        • Professional Services
                    • Brachytherapy
                      • Elekta Studio
                      • ImagingRing
                      • Venezia
                      • Flexitron
                      • Geneva
                      • Head and Neck
                      • Bronchus and Oesophagus
                      • Breast
                      • Skin
                      • Prostate
                      • Rectum
                      • Bladder
                      • Gynecology
                      • Oncentra Brachy
                    • Neurosurgery
                      • Leksell Vantage Stereotactic System
                      • Leksell Stereotactic System
                    • Veterinary Radiation Therapy
                    • Life Sciences
                      • Elekta Kaiku
                  • Services
                    • Elekta Care
                    • Elekta Care Support Services
                    • Elekta Care 360
                    • Elekta Care Learning
                    • Elekta Care Community
                    • Elekta Partner Community
                  • Patients
                    • MR-Linac Treatment
                    • Brachytherapy Treatment
                    • Gamma Knife Treatment
                    • Radiation Therapy Treatment
                    • Treatment Centers
                  • Company
                    • Partnering with Elekta
                    • About us
                      • Board of Directors
                      • Code of Conduct
                      • Corporate Citizenship
                      • Executive Committee
                      • Integrity Line
                      • Programs
                      • Risk management
                      • Sponsorship and Donation
                      • Story
                    • Sustainability
                    • Corporate Governance
                      • Shareholders’ meetings
                        • Board of Directors
                          • Executive Committee
                            • Auditors
                            • Reports
                          • Investors
                            • Investment case
                              • Outlook
                              • Market and Trends
                                • The share
                                  • Financials
                                    • Funding
                                      • Reports & presentations
                                      • Press releases
                                      • IR calendar
                                      • IR contacts
                                    • Newsroom
                                      • Press Releases
                                      • FOCUS Magazine
                                      • Events
                                      • Image bank
                                    • Careers at Elekta
                                      • Jobs
                                    • Reimbursement Support & Policy
                                  • Contact
                                  • Medical Affairs
                                  • Regulatory Affairs
                                  • Suppliers
                                    • About Elekta Procurement
                                    • Sustainable Sourcing
                                    • Performance Management
                                      • Production Part Approval Process
                                      • Supplier Escalation Form
                                      • Non Conformance Management
                                      • Supplier Performance Management
                                      • Obsolescence Management
                                    • Compliance Management
                                    • Invoicing Process
                                    • Elekta T&C
                                    • Documents & Training
                                    • Our Global Presence
                                  • ASTRO23
                                  • Facebook logo
                                  • LinkedIn logo
                                  • Twitter logo
                                  • Instagram icon
                                  • YouTube play button

                                  Interim report, May–January 2020/21

                                  February 25, 2021

                                  Momentum and growth

                                  In Elekta’s third quarter, we experienced an improving market situation and gained better access to customers. Both orders and revenue recovered, and we returned to growth. Elekta is successfully driving the second phase of the MR-Linac paradigm shift with Unity in the lead.

                                  Gustaf Salford
                                  President and CEO

                                  Third quarter

                                  • Gross order intake amounted to SEK 3,954 M (4,276), corresponding to a 2 percent increase in constant currency
                                  • Net sales were SEK 3,581 M (3,656), corresponding to a 7 percent growth in constant currency
                                  • Gross margin amounted to 38.7 (42.0) percent
                                  • EBITA amounted to SEK 664 M (648), corresponding to an EBITA margin of 18.5 percent (17.7)
                                  • Earnings per share was SEK 0.84 (0.81) before/after dilution
                                  • Cash flow after continuous investments improved by SEK 720 M to SEK 496 M (-224)

                                  First nine months

                                  • Gross order intake amounted to SEK 12,032 M (12,702), corresponding to a 1 percent growth in constant currency
                                  • Net sales were SEK 10,096 M (10,593), corresponding to a 2 percent increase in constant currency
                                  • Gross margin amounted to 41.6 (41.8) percent
                                  • EBITA amounted to SEK 1,967 M (1,635), corresponding to an EBITA margin of 19.5 percent (15.4)
                                  • Earnings per share was SEK 2.39 (1.77) before/after dilution
                                  • Cash flow after continuous investments improved by SEK 1,660 M to SEK 886 M (-774)

                                  Significant events after the quarter

                                  • Elekta has appointed Johan Adebäck as CFO with immediate effect
                                  • First cancer centers begin using initial release of Elekta’s MOSAIQ 3 series
                                     


                                  1 After continuous investments.
                                  2 Before / after dilution.
                                  3 Based on constant currency.
                                   

                                  # # #

                                  For further information, please contact:
                                  Cecilia Ketels, Head of Investor Relations
                                  Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
                                  Time zone: CET: Central European Time

                                  Johan Adebäck, CFO, Elekta AB (publ)
                                  Tel: +46 70 873 33 21, e-mail: johan.adeback@elekta.com
                                  Time zone: CET: Central European Time

                                  This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on February 25, 2020. (REGMAR) 

                                  About Elekta
                                  For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

                                  Downloads

                                  • Release

                                  Images

                                  • Group summary.png
                                  • Products
                                    • Radiation Therapy
                                    • Stereotactic Radiosurgery
                                    • Oncology Software
                                    • Brachytherapy
                                    • Neurosurgery
                                    • Veterinary Radiation Therapy
                                    • Life Sciences
                                  • Services
                                    • Elekta Care
                                    • Elekta Care Support Services
                                    • Elekta Care 360
                                    • Elekta Care Learning
                                    • Elekta Care Community
                                    • Elekta Partner Community
                                  • Patients
                                    • MR-Linac Treatment
                                    • Brachytherapy Treatment
                                    • Gamma Knife Treatment
                                    • Radiation Therapy Treatment
                                    • Treatment Centers
                                  • Company
                                    • Partnering with Elekta
                                    • About us
                                    • Sustainability
                                    • Corporate Governance
                                    • Investors
                                    • Newsroom
                                    • Careers at Elekta
                                    • Country and regional pages
                                    • Digital Product Security
                                    • Offices
                                  • Facebook logo
                                  • LinkedIn logo
                                  • Twitter logo
                                  • Instagram icon
                                  • YouTube play button
                                  • ©2023 Elekta
                                  • Legal notices
                                  • Privacy policy
                                  • Cookies
                                  • Subscription center

                                  Important Safety Information: Radiation therapy is not appropriate for all patients. Radiation treatments may cause side effects that can vary depending on the part of the body being treated. In some patients, they can be severe. Treatment sessions may vary in complexity and time. Refer to individual product labeling (instructions for use) for more complete information on product safety and effectiveness for its intended use.

                                  © 2023 Elekta

                                  • Legal notices
                                  • Privacy policy
                                  • Cookies
                                  • Subscription center

                                  Important Safety Information: Radiation therapy is not appropriate for all patients. Radiation treatments may cause side effects that can vary depending on the part of the body being treated. In some patients, they can be severe. Treatment sessions may vary in complexity and time. Refer to individual product labeling (instructions for use) for more complete information on product safety and effectiveness for its intended use.